262 related articles for article (PubMed ID: 24133627)
21. A randomized trial of aspirin to prevent colorectal adenomas.
Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
23. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
Asano TK; McLeod RS
Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
[TBL] [Abstract][Full Text] [Related]
24. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
Benamouzig R; Uzzan B; Little J; Chaussade S
Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of aspirin use and the risk for colorectal adenoma.
Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
[TBL] [Abstract][Full Text] [Related]
26. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.
Burn J; Bishop DT; Chapman PD; Elliott F; Bertario L; Dunlop MG; Eccles D; Ellis A; Evans DG; Fodde R; Maher ER; Möslein G; Vasen HF; Coaker J; Phillips RK; Bülow S; Mathers JC;
Cancer Prev Res (Phila); 2011 May; 4(5):655-65. PubMed ID: 21543343
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Metformin in Treatment of Adenomas in Patients with Familial Adenomatous Polyposis.
Park JJ; Kim BC; Hong SP; Seo Y; Lee HS; Park YS; Na SY; Park SC; Park J; Kim JH; Moon CM; Huh KC; Park SJ; Cheon JH; Kim WH; Kim TI
Cancer Prev Res (Phila); 2021 May; 14(5):563-572. PubMed ID: 33509804
[TBL] [Abstract][Full Text] [Related]
28. NSAIDs and colorectal cancer prevention.
Iwama T
J Gastroenterol; 2009; 44 Suppl 19():72-6. PubMed ID: 19148797
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
30. Aspirin: still learning about the wonder drug.
Hawk ET; Viner JL
Gut; 2003 Nov; 52(11):1535-6. PubMed ID: 14570718
[No Abstract] [Full Text] [Related]
31. [Acetylsalicylic acid for prevention of colorectal adenomas. The APP Study].
Schmiegel W; Reinacher-Schick A
Internist (Berl); 2003 Oct; 44(10):1322-4. PubMed ID: 14689093
[No Abstract] [Full Text] [Related]
32. Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis.
Cruz-Correa M; Hylind LM; Marrero JH; Zahurak ML; Murray-Stewart T; Casero RA; Montgomery EA; Iacobuzio-Donahue C; Brosens LA; Offerhaus GJ; Umar A; Rodriguez LM; Giardiello FM
Gastroenterology; 2018 Sep; 155(3):668-673. PubMed ID: 29802852
[TBL] [Abstract][Full Text] [Related]
33. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
Prescrire Int; 2006 Feb; 15(81):13-5. PubMed ID: 16548099
[TBL] [Abstract][Full Text] [Related]
35. Aspirin and familial adenomatous polyposis: coming full circle.
Chan AT
Cancer Prev Res (Phila); 2011 May; 4(5):623-7. PubMed ID: 21543340
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.
Stone JK; Mehta NA; Singh H; El-Matary W; Bernstein CN
Fam Cancer; 2023 Oct; 22(4):413-422. PubMed ID: 37119510
[TBL] [Abstract][Full Text] [Related]
37. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
38. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
Huls G; Koornstra JJ; Kleibeuker JH
Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
[TBL] [Abstract][Full Text] [Related]
39. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
Thun MJ; Henley SJ; Patrono C
J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387
[TBL] [Abstract][Full Text] [Related]
40. [Aspirin for Chemoprevention of Colorectal Adenoma and Cancer].
Ishikawa H
Gan To Kagaku Ryoho; 2021 Dec; 48(12):1425-1428. PubMed ID: 34911904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]